MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Intraventricular baclofen and bilateral pallidotomy in a pediatric patient with acquired generalized dystonia and refractory status dystonicus

O,. Escobar, S. Ordóñez-Cure, J. Arias-Angulo, L. Ortega-Bolaños, V. Martínez-Villota (Cali, Colombia)

Meeting: 2024 International Congress

Abstract Number: 1380

Keywords: Dystonia: Treatment, Pallidotomy

Category: Dystonia: Clinical Trials and Therapy

Objective: To present management with intraventricular baclofen followed by bilateral pallidotomy in a 3-years-old child who presents a refractory status dystonicus secondary to hypoxic-ischemic encephalopathy

Background: Refractory Status dystonicus (SD) is a life-threatening emergency, surgical treatments such as deep brain stimulation (DBS) have demonstrated efficacy, alternatives include bilateral pallidotomy (BP) for patients with cognitive impairment, young age, cachectic state, follow‐up limitations, failure or contraindications for DBS; Intrathecal baclofen (ITB) has reports benefit in a small number of patients; and intraventricular baclofen (IVB) when ITB is not feasible

Method: A previously healthy 3-year-old boy presented with secondary severe hypoxic-ischemic encephalopathy after cardiorespiratory arrest due to upper airway obstruction, which triggered SD with severe spastic quadriparesis refractory to medical treatment and prolonged mechanical ventilation.  The patient required IVB, after a positive intrathecal baclofen test, (reduction of modified Ashworth scale score from 5 to 3 generalized and 8 to 2 episodes per day of SD), and reducing the dose of sedative drugs by 50%. IVB was performed through neuronavigation until a 850 mcg/day within the first two weeks, with good spasticity but fluctuating dystonia response. After a surgical review of adequate pump patency with contrast infusion testing, a bilateral pallidotomy was considered due to the poor neurological prognosis and malnutrition status

Results: The preoperative score on the Burke Fahn Marsden rating scale was 96 points. After BP the initial response was partial, but gradually the patient achieved resolution of the SD and weaning from mechanical ventilation. The final dose of IVB baclofen is 1050 mcg/day.

Conclusion: Bilateral pallidotomy and IVB should be considered in the treatment of refractory SD, particularly for patients with contraindications for DBS and concurrent severe spasticity. The literature review  support this findings, providing an overview that can guide palliative management in similar cases

Fig1. 3th Intraventricular catheter IVB

Fig1. 3th Intraventricular catheter IVB

Figure 2. Baclofen pump in abdominal region

Figure 2. Baclofen pump in abdominal region

Figure 3. Status dystonicus in pediatric ICU

Figure 3. Status dystonicus in pediatric ICU

Figure 4. MRI showing BP in a T2

Figure 4. MRI showing BP in a T2

To cite this abstract in AMA style:

O,. Escobar, S. Ordóñez-Cure, J. Arias-Angulo, L. Ortega-Bolaños, V. Martínez-Villota. Intraventricular baclofen and bilateral pallidotomy in a pediatric patient with acquired generalized dystonia and refractory status dystonicus [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/intraventricular-baclofen-and-bilateral-pallidotomy-in-a-pediatric-patient-with-acquired-generalized-dystonia-and-refractory-status-dystonicus/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/intraventricular-baclofen-and-bilateral-pallidotomy-in-a-pediatric-patient-with-acquired-generalized-dystonia-and-refractory-status-dystonicus/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley